Davis Todd C
Chief Executive Officer · 14 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | LGND | LIGAND PHARMACEUTICALS INC | J | 132 | $160.71 | $21,213.65 | filing |
| 2026-06-11 | PTHS | Pelthos Therapeutics Inc. | Buy | 35,445 | $27.80 | $985,534.05 | filing |
| 2026-06-11 | PTHS | Pelthos Therapeutics Inc. | Buy | 503 | $28.73 | $14,449.23 | filing |
| 2026-03-02 | LGND | LIGAND PHARMACEUTICALS INC | Award | 10,495 | $0.00 | $0.00 | filing |
| 2026-02-15 | LGND | LIGAND PHARMACEUTICALS INC | Tax withholding | 4,255 | $183.83 | $782,196.65 | filing |
| 2026-02-15 | LGND | LIGAND PHARMACEUTICALS INC | Tax withholding | 2,805 | $183.83 | $515,643.15 | filing |
| 2026-02-15 | LGND | LIGAND PHARMACEUTICALS INC | Tax withholding | 2,039 | $183.83 | $374,829.37 | filing |
| 2026-02-14 | LGND | LIGAND PHARMACEUTICALS INC | Tax withholding | 15,600 | $183.83 | $2.9M | filing |
| 2026-02-14 | LGND | LIGAND PHARMACEUTICALS INC | Tax withholding | 8,178 | $183.83 | $1.5M | filing |
| 2026-02-14 | LGND | LIGAND PHARMACEUTICALS INC | Award | 20,782 | $0.00 | $0.00 | filing |
| 2026-02-14 | LGND | LIGAND PHARMACEUTICALS INC | Award | 39,644 | $0.00 | $0.00 | filing |
| 2025-12-04 | LGND | LIGAND PHARMACEUTICALS INC | Gift | 130 | $0.00 | $0.00 | filing |
| 2025-07-01 | PTHS | Pelthos Therapeutics Inc. | C | 1,500,000 | $10.00 | $15.0M | filing |
| 2025-06-30 | LGND | LIGAND PHARMACEUTICALS INC | J | 233 | $91.08 | $21,221.06 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.